| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Vogelbaum Martin is a Director at Tvardi Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 3 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 10,800 | $10.28 | $111,024.00 | -19.4% | +12.2% | -79.9% | |
| Jun 7, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 8,640 | $13.05 | $112,752.00 | -30.0% | +16.0% | -34.1% | |
| Nov 17, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 6,000 | $16.09 | $96,540.00 | -29.4% | - | - | |
| Mar 17, 2016 | TVRD Tvardi Therapeutics, Inc. | Director | Buy | 400,000 | $4.87 | $1,949,202.91 | +7.3% | - | - |